Stage |
Non-metastatic | 1 | | |
Metastatic | 3.2 | 2.1 to 4.7 | <0.001 |
Treatment intent |
Non-radically treatable intent | 1 | | |
Radically treatable intent | 0.3 | 0.2 to 0.5 | <0.001 |
Site of primary |
Lower/upper gastrointestinal | 1 | | |
Genitourinary | 0.7 | 0.4 to 1.2 | 0.177 |
Gynaecological | 0.6 | 0.3 to 0.9 | 0.027 |
Head and neck | 0.3 | 0.2 to 0.8 | 0.008 |
Breast | 0.3 | 0.04 to 2.1 | 0.218 |
Variable overall | | | 0.030 |
Treatment received (prior to progression) |
No treatment received (reference) | 1 | | |
Chemotherapy | 0.05 | 0.02 to 0.12 | <0.001 |
Radiotherapy | 0.05 | 0.02 to 0.14 | <0.001 |
Surgery | 0.02 | 0.01 to 0.05 | <0.001 |
Combination chemoradiotherapy | 0.03 | 0.01 to 0.07 | <0.001 |
Combination chemosurgery | 0.02 | 0.01 to 0.04 | <0.001 |
Variable overall | | | <0.001 |